Department of cardiology and macrovascular disease, Beijing Tiantan Hospital, Capital Medical University, No.119 South Fourth Ring West Road, Fengtai District, Beijing, 100070, People's Republic of China.
Phillips Academy Andover, Andover, MA, USA.
J Med Syst. 2021 Jan 3;45(1):9. doi: 10.1007/s10916-020-01703-6.
The coronavirus disease 2019 (COVID-19), which is caused by a novel coronavirus (SARS-COV-2), has compromised health care systems and normal management of patients with cardiovascular diseases [1-3]. Patients with non-communicable diseases, including acute myocardial infarction (AMI) are vulnerable to this stress [4, 5]. Acute ST segment elevation myocardial infarction (STEMI), the most critical type of AMI, is associated with high mortality even with modern medicine [6-8]. Timely reperfusion therapy is critical for STEMI patients because a short ischemia time is associated with better clinical outcomes and lower acute and long -term mortality [9-12]. The COVID-19 pandemic placed the management of STEMI patients in a difficult situation due to the need to balance timely reperfusion therapy and maintaining strict infection control practices [13, 14]. Telemedicine, which is used to deliver health care services using information or communication technology, provides an opportunity to carry out the evaluation, diagnosis, and even monitor the patients after discharge when social distancing is needed [15]. In this article, we reported our preliminary experience with the usefulness of telemedicine in managing STEMI patients during the COVID-19 pandemic. We also provided a review of this topic.
新型冠状病毒病（COVID-19）是由新型冠状病毒（SARS-CoV-2）引起的，它已经影响了医疗保健系统和心血管疾病患者的常规管理[1-3]。包括急性心肌梗死（AMI）在内的非传染性疾病患者易受这种压力影响[4,5]。急性 ST 段抬高型心肌梗死（STEMI）是最严重的 AMI 类型，即使采用现代医学，其死亡率仍然很高[6-8]。对于 STEMI 患者，及时再灌注治疗至关重要，因为较短的缺血时间与更好的临床结果和更低的急性和长期死亡率相关[9-12]。由于需要平衡及时再灌注治疗和严格的感染控制措施，COVID-19 大流行使 STEMI 患者的管理陷入困境[13,14]。远程医疗是一种利用信息或通信技术提供医疗服务的方法，在需要保持社交距离时，它为评估、诊断甚至监测出院后的患者提供了机会[15]。在本文中，我们报告了在 COVID-19 大流行期间使用远程医疗管理 STEMI 患者的初步经验，并对这一主题进行了回顾。
